ArticleJournal of hepatocellular carcinoma2026

Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2).

Yuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.